I still have my 1989 shipment of Biturbo Stata version 2.05 and Stage 1.0 Graphics Editor, on five 3.5-inch, 720 Kb floppies. On opening at random my copy of the version 2.05 reference manual (copyright March 1989 c Computing Resource Center, Los Angeles, California), the page fell open at page 539, a summary of something called Stat.Kit. I recalled then the excitement of the arrival of "kits"; they were the forerunners of the now familiar and quintessential ado-files. In those days, there were 4 such kits (Stat.Kit, Graph.Kit, Data.Kit, Survive.Kit), and they provided a variety of programs in each relevant area. You typed, for example, run Stat.Kit, and the associated 17 programs were loaded into memory. After that you used them exactly as one now does an ado-file.
On reflection, Stata has a few key features that I value above all. First, I will illustrate one of these features in a little detail, and later I will briefly mention the others. This feature is backwards compatibility, which in Stata lingo is known as "version control". As a simple experiment designed to test version control, I wrote and ran in Stata 8.2 the following do-file: with on average about 2.5 mpg greater values, and run an unpaired t-test comparing mpg with mpg2. Here is the output as stored in stata.log: 
Lo and behold, Stata 8.2 runs correctly under version 2.05 control using 2.05 program code and data. This to my mind is impressive. How many other statistical packages would stand up to such a severe test? For me, version control is an apparently unglamorous property of Stata that shows StataCorp's strong commitment to the practical needs of its users, and is one reason why Stata still has a rosy future. I dread to think how many lines of C program code sit behind the scenes supporting the innocent-looking version # command. Surely this is virtuoso computer programming of a high order?
Other essential features of Stata I particularly value are its graphics, its simple but elegant command syntax (which in essence has not changed since version 2.05), its seamless programmability via ado-files, and last, but by no means least, its excellent documentation. I do recall that having fast, high-resolution graphics was in 1989 an important selling point and a key determinant of why I bought Stata. The fact that formulas are given in the manual even for quite complex mathematical calculations such as the partial likelihood in a Cox regression model has been immensely useful, and StataCorp even now continues to pay attention to improving this aspect of the product. I could add other far-sighted innovations that were even rather shocking at the time of their introduction, such as increasing levels of integration with the Internet for updating Stata and for installing add-on packages. Certainly the list-server Statalist has played a useful role in the development of user awareness, although I myself don't find much time to access it nowadays. One must also mention the Stata Journal and its predecessor, the Stata Technical Bulletin. No serious package can be without such a publication.
Is Stata now perfect? Of course not. Areas in which I would like to see improvements include documentation of graphics and GUI dialog programming, greater searchability and flexibility of the help system (I have lost count of the number of times I have trawled through the help system in search of some obscure graphics option), acceleration of drawing a graph, and a facility to make it easier to write help files in Stata's markup language, SMCL. A graphics editor would be nice too; my 1989 shipment included Stage 1.0, the first and only edition of the Stata graphics editor, a fine program that has not yet been replaced.
Above all, though, StataCorp's encouragement of users to get involved and StataCorp's habit of valuing and responding to their subsequent efforts have been some of the most delightful and productive aspects of Stata. If that interaction is ever lost, Stata will probably die.
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